{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiagztxp22ihdp46qzpcx6jjadjv6cwtcjstpdtixwpnxgpfzrc7yu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnabrjpyvcz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidfxqoeomluectgoxsidilzppx2aw5u5f2pakfga3zp7v3pgxrsmm"
    },
    "mimeType": "image/jpeg",
    "size": 762595
  },
  "path": "/news/2026-06-psma-pet-reveals-bone-metastases.html",
  "publishedAt": "2026-06-01T09:40:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients, a critical indicator of a patient's long-term survival. Outcomes data revealed that patients with even just one bone metastasis experience faster disease progression and worse overall survival.",
  "title": "PSMA PET reveals bone metastases missed by standard imaging"
}